[Momentis Surgical in Startup News] Momentis Surgical receives FDA 510(k) clearance for second generation Anovo® robotic platform, introducing haptic feedback and dual-mode articulation

Momentis Surgical Ltd., a leader in robotic-assisted surgical innovation, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for its second-generation Anovo^® robotic surgical platform. 

Read more here.